Management of Valvular Disease During Pregnancy: Evolving Role of Percutaneous Treatment
Valvular heart disease (VHD) is encountered in approximately 1% of pregnancies, significantly increasing both maternal and foetal risk. Rheumatic VHD remains the most common form in non-Western countries, whereas congenital heart disease dominates in the Western world. The risk of complications vari...
Guardado en:
Autores principales: | Chiara Fraccaro, Noemie Tence, Giulia Masiero, Nicole Karam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a902c31fc5904d3d8d06c2698a2c2659 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic Angiograms and Percutaneous Coronary Interventions in Pregnancy
por: Phyo Htet Khaing, et al.
Publicado: (2020) -
Multivalvular Disease: Percutaneous Management in 2019 and Beyond
por: Magdalena Erlebach, et al.
Publicado: (2019) -
Exercise Right Heart Catheterisation in Cardiovascular Diseases: A Guide to Interpretation and Considerations in the Management of Valvular Heart Disease
por: Felipe H Valle, et al.
Publicado: (2021) -
Unexpected use of ‘additional-stent’ during elective percutaneous coronary intervention
por: Kartik Jadhav, et al.
Publicado: (2021) -
Outcomes After Percutaneous Coronary Intervention in Women: Are There Differences When Compared with Men?
por: Usha Rao, et al.
Publicado: (2019)